ILMN logo

Illumina Inc (ILMN)

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which seque...

NASDAQHealthcareDiagnostics & ResearchUSA

Company Profile

Stock Code
ILMN
ISIN Code
US4523271090
Currency
US Dollar (USD)
IPO Date
2000-07-28

Contact Information

Company Address
5200 Illumina Way, San Diego, CA, United States, 92122
Contact Phone
858 202 4500
Company Website
https://www.illumina.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
8.67%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99